Related Experiment Video
Updated: Jun 21, 2025

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit
Published on: July 13, 2019
Implementing a 4% EDTA Central Catheter Locking Solution as a Quality Improvement Project in a Large Canadian
Leanne Tremain1, Ari Collerman, Prathiba Harsha
1Author Affiliations: Hamilton Health Sciences, Hamilton, Ontario, Canada (Tremain, Collerman, Harsha, Ntow, Main, Wohlgemut, Brown, Scott, Dietrich); McMaster University, Hamilton, Ontario, Canada (Ntow, Main, Scott).
Four percent ethylenediaminetetraacetic acid (4% EDTA) significantly reduced central line-associated bloodstream infections (CLABSIs) by 59% in oncology and critical care units. While it did not impact catheter occlusions, 4% EDTA showed promise for improving patient safety.
Area of Science:
- Infection Control
- Vascular Access
- Patient Safety
Background:
- Central vascular access devices (CVADs) are crucial for oncology and critical care patients but increase risks of central line-associated bloodstream infections (CLABSIs) and thrombotic occlusions.
- CLABSIs saw a 63% rise during the COVID-19 pandemic, necessitating novel interventions.
- Four percent ethylenediaminetetraacetic acid (4% EDTA) is an antimicrobial agent known to reduce CLABSIs, occlusions, and biofilm formation.
Purpose of the Study:
- To evaluate the effectiveness of 4% EDTA as a catheter locking solution in reducing CLABSIs and central catheter occlusions.
- To assess the impact of 4% EDTA on patient safety in adult cancer and critical care units.
Main Methods:
- A retrospective pre-post quality improvement project was conducted across all adult cancer and critical care units at a regional cancer center.
- The study compared CLABSI and occlusion rates before and after the implementation of 4% EDTA as a locking solution.
Main Results:
- A statistically significant 59% decrease in CLABSIs per 1000 catheter days was observed after implementing 4% EDTA (36 cases in 16 months pre- vs. 6 cases in 6 months post-implementation).
- No significant difference was found in the rate of catheter occlusions (alteplase use) between the pre- and post-implementation periods.
- Patient outlook was largely positive or neutral (88%), with nurses expressing a preference for prefilled syringes of 4% EDTA.
Conclusions:
- The implementation of 4% EDTA as a catheter locking solution led to a significant reduction in CLABSIs in oncology and critical care settings.
- While 4% EDTA did not significantly affect catheter occlusion rates, its impact on CLABSI reduction warrants further investigation.
- Further randomized controlled trials are recommended to establish a definitive causal relationship and explore optimal use, considering potential influences like the pandemic and nursing shortages.
More Related Videos
06:59A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017